Foundation Fighting Blindness

7MM Retinitis Pigmentosa (RP) Market Insights, 2017-2030 - United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Retrieved on: 
星期四, 六月 25, 2020
Blindness, Channelopathies, RTT, Retinitis pigmentosa, Retinitis, Foundation Fighting Blindness, Health

The epidemiology segment also provides the Retinitis Pigmentosa epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Key Points: 
  • The epidemiology segment also provides the Retinitis Pigmentosa epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • The drug chapter segment of the Retinitis Pigmentosa report encloses the detailed analysis of Retinitis Pigmentosa marketed drugs and late stage (phase III) pipeline drugs.
  • This section provides the total Retinitis Pigmentosa market size and market size by therapies in the United States.
  • The total Retinitis Pigmentosa market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom are provided in this section.

Foundation Fighting Blindness to Host Virtual VISIONS 2020 Conference

Retrieved on: 
星期二, 六月 16, 2020
Foundation Fighting Blindness

COLUMBIA, Md., June 16, 2020 /PRNewswire/ --The Foundation Fighting Blindness ,the world's leading organization searching for treatments and cures for inherited retinal diseases, will host its VISIONS 2020 national conference virtually on June 25-27, 2020.

Key Points: 
  • COLUMBIA, Md., June 16, 2020 /PRNewswire/ --The Foundation Fighting Blindness ,the world's leading organization searching for treatments and cures for inherited retinal diseases, will host its VISIONS 2020 national conference virtually on June 25-27, 2020.
  • Participants of Virtual VISIONS 2020 are invited to join live for the opening presentation, "Mission Possible!
  • presented by Dr. Shannon Boye, associate professor at University of Florida, and Dr. Ben Yerxa, chief executive officer at the Foundation Fighting Blindness.
  • "Our new virtual approach to VISIONS 2020 will still allow our Fighting Blindness community to come together and learn about the tremendous progress being made by Foundation funded scientists and clinical researchers," says Ben Yerxa, PhD, chief executive officer at the Foundation Fighting Blindness.

Foundation Fighting Blindness Launches Upgraded My Retina Tracker® Registry for People with Inherited Retinal Diseases (IRDs)

Retrieved on: 
星期五, 五月 15, 2020
Foundation Fighting Blindness, Retina, Vision, Senses, Perception, Blindness, Emerging technologies, The Llura Liggett Gund Award

COLUMBIA, Md., May 15, 2020 /PRNewswire/ -- The Foundation Fighting Blindness, the world's leading organization searching for treatments and cures for inherited retinal diseases, has introduced many improvements and upgrades to its My Retina Tracker Registry.

Key Points: 
  • COLUMBIA, Md., May 15, 2020 /PRNewswire/ -- The Foundation Fighting Blindness, the world's leading organization searching for treatments and cures for inherited retinal diseases, has introduced many improvements and upgrades to its My Retina Tracker Registry.
  • "The My Retina Tracker Registry has been an invaluable resource for both IRD patients and research communities.
  • Current sponsors of the new My Retina Tracker Registry include: The George Gund Foundation, Eloxx Pharmaceuticals, Sofia Sees Hope, AGTC and MeiraGTx.
  • Established in 1971, the Foundation Fighting Blindness is the world's leading private funding source for retinal degenerative disease research.

Foundation Fighting Blindness Announces National Virtual VisionWalk Day

Retrieved on: 
星期二, 五月 5, 2020
Foundation Fighting Blindness, RTT, Visual impairment

COLUMBIA, Md., May 5, 2020 /PRNewswire/ -- The Foundation Fighting Blindness has transformed all VisionWalk in-person events scheduled to take place through June 2020, into one nationwide virtual experience taking place on Saturday, June 6, 2020.

Key Points: 
  • COLUMBIA, Md., May 5, 2020 /PRNewswire/ -- The Foundation Fighting Blindness has transformed all VisionWalk in-person events scheduled to take place through June 2020, into one nationwide virtual experience taking place on Saturday, June 6, 2020.
  • This National Virtual VisionWalk Day is a new opportunity for communities to still come together, virtually, and celebrate the Foundation's accomplishments of funding research leading to treatments and cures for blinding retinal diseases.
  • Join the National Virtual VisionWalk on Saturday, June 6, 2020 by visiting, VisionWalk.org .Together, we step closer to fighting blindness.
  • Established in 1971, the Foundation Fighting Blindness is the world's leading private funding source for retinal degenerative disease research.

Company Profile for Kubota Vision Inc. (dba of Acucela Inc.)

Retrieved on: 
星期三, 四月 1, 2020
Biotechnology, Medical devices, Health, Pharmaceutical, Optical, Ophthalmology, Vision, Organ systems, Blindness, Diabetes, Diabetic retinopathy, Retinitis pigmentosa, Retinopathy, Stargardt disease, Retina, Retinitis, Foundation Fighting Blindness, Ophthalmology, Vision, Organ systems, Blindness, Diabetes, Diabetic retinopathy, Retinitis pigmentosa, Retinopathy, Stargardt disease, Retina, Retinitis, Foundation Fighting Blindness

Kubota Vision Inc. is a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596) committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide.

Key Points: 
  • Kubota Vision Inc. is a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596) committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide.
  • Kubota Visions development pipeline include drug candidates for the treatment of diabetic retinopathy, Stargardt disease, and optogenetics-based gene therapy for the treatment of retinitis pigmentosa.
  • The company is also developing a handheld OCT device for the monitoring of neovascular retinal diseases, to be used directly by patients.

ProQR Therapeutics Teams Up with the Foundation Fighting Blindness and Blueprint Genetics to Support the My Retina Tracker® Program for People Living with Inherited Retinal Diseases

Retrieved on: 
星期四, 二月 6, 2020
Ophthalmology, Vision, Retina, Visual system, Foundation Fighting Blindness, Senses

The My Retina Tracker Program is currently the most effective pathway for Biopharma to enhance patient identification, said Tero-Pekka Alastalo, Executive Director, Medical at Blueprint Genetics.

Key Points: 
  • The My Retina Tracker Program is currently the most effective pathway for Biopharma to enhance patient identification, said Tero-Pekka Alastalo, Executive Director, Medical at Blueprint Genetics.
  • Although it is not required for participation, this program offers an easy opportunity to join the My Retina Tracker Registry.
  • www.proqr.com
    Established in 1971, the Foundation Fighting Blindness is the worlds leading private funding source for retinal degenerative disease research.
  • Blueprint Genetics is one of the fastest growing genetic diagnostics businesses globally in the field of clinical genetic testing of rare inherited diseases.

Foundation Fighting Blindness Celebrates 15th Year of VisionWalk with New Branding

Retrieved on: 
星期四, 一月 9, 2020
Foundation Fighting Blindness, Brand, Fundraising, Economy, Articles, Academic disciplines

Columbia, MD, Jan. 09, 2020 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness launches 2020 with a bold, new logo and branding for its signature fundraising event, VisionWalk.

Key Points: 
  • Columbia, MD, Jan. 09, 2020 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness launches 2020 with a bold, new logo and branding for its signature fundraising event, VisionWalk.
  • VisionWalk includes more than 35 walk events in cities throughout the United States.
  • The new brand identity further connects this signature fundraising event to the new Foundation logo that was adopted early in 2019.
  • Established in 1971, the Foundation Fighting Blindness is the worlds leading private funding source for retinal degenerative disease research.

Foundation Fighting Blindness Launches Natural History Study for People with Retinitis Pigmentosa Caused by EYS Gene Mutations

Retrieved on: 
星期三, 十一月 27, 2019
Ophthalmology, Blindness, Channelopathies, RTT, Retinitis pigmentosa, Retinitis, Retinal degeneration, Foundation Fighting Blindness, Vision, Organ systems

Columbia, MD, Nov. 27, 2019 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness has launched a natural history study (NCT04127006) for people with retinitis pigmentosa (RP) caused by mutations in the gene EYS called the Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS).

Key Points: 
  • Columbia, MD, Nov. 27, 2019 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness has launched a natural history study (NCT04127006) for people with retinitis pigmentosa (RP) caused by mutations in the gene EYS called the Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS).
  • This is an important study because it is characterizing one of the most common genetic causes of retinitis pigmentosa.
  • Natural history studies, such as this, are critical for understanding the impact any therapy may have on the natural progression of disease.
  • These efforts will help accelerate the development of treatments, says Mark Pennesi, MD, PhD, Oregon Health & Science University, and study chair for Pro-EYS.

SparingVision Nominated for the Prix Galien MedStart'up in the Category “Best Collaboration Dedicated to the Developing or Underserved Populations Worldwide”

Retrieved on: 
星期一, 十月 21, 2019
Biotechnology, Optical, Surgery, General Health, Health, Genetics, Clinical trials, Other Health, Ophthalmology, Blindness, Channelopathies, RTT, Retinitis pigmentosa, Retinal degeneration, Medical specialties, Organ systems, Retinitis, Foundation Fighting Blindness, Progressive retinal atrophy

Organized by the Fondation Galien and Business France, the Prix Galien MedStart'Up rewards the most promising start-ups in the healthcare sector, created by international partnerships between French and North American innovators.

Key Points: 
  • Organized by the Fondation Galien and Business France, the Prix Galien MedStart'Up rewards the most promising start-ups in the healthcare sector, created by international partnerships between French and North American innovators.
  • The Fighting Blindness Foundation, created in 1971, is one of the largest foundations in the United States for degenerative retinal diseases.
  • SparingVision has been selected for its treatment that fights against the most common retinitis pigmentosa of hereditary retinal degeneration.
  • SparingVision is developing SPVN06, a gene-independent drug candidate to treat retinitis pigmentosa, the most common inherited retinal degeneration.

Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness launch an open access program for patients with inherited retinal disease in the United States

Retrieved on: 
星期三, 十月 2, 2019
Ophthalmology, Vision, Organ systems, Foundation Fighting Blindness, Retina, Blindness, Rare diseases, Progressive retinal atrophy, Retinoschisis

The new program is an expansion of the My Retina Tracker genetic testing program established in 2017, when the Foundation Fighting Blindness partnered with Blueprint Genetics and InformedDNA to launch the My Retina Tracker genetic testing study.

Key Points: 
  • The new program is an expansion of the My Retina Tracker genetic testing program established in 2017, when the Foundation Fighting Blindness partnered with Blueprint Genetics and InformedDNA to launch the My Retina Tracker genetic testing study.
  • Now, My Retina Tracker will become available to all US patients with a clinical diagnosis of an inherited retinal disease (IRD).
  • The My Retina Tracker genetic testing program is expanding to be an open access, no-cost program for patients with a clinical diagnosis of an inherited retinal disease.
  • Established in 1971, the Foundation Fighting Blindness is the worlds leading private funding source for retinal degenerative disease research.